Zhejiang New Donghai Pharmaceutical Co., Ltd.

Zhejiang New Donghai Pharmaceutical Co., Ltd.
Mr. Bin Liu
101 - 500 People
North America South America Eastern Europe Southeast Asia Africa Oceania Mid East Eastern Asia Western Europe
Manufacturer, Trading Company
Sulpiride,levosulpiride,7ADCA,n-ethye-2-amtnomethyll-pyrolidine,(s)-n-ethye-2-amtnomethyll-pyrolidine,olanzapine,smia
Zhejiang New Donghai Pharmaceutical Co., Ltd. was founded in 1981. Located in Zhedongnan chemical APIs import and export base in Taizhou City, New Donghai is a shareholding complex enterprise, with the production of pharmaceutical intermediates and APIs as main business. At present, our business covers production, research, trade and investment. As an ISO9001:2000 quality system, ISO14001:2004 environment system and GB/T28001:2001 OHSAS system approved company, New Donghai now is a hi-tech enterprise of Zhejiang Province, and we have 4 subsidiaries, one research organization of Zhejiang Province and one R&D Centre of Zhejiang Province. Moreover, we are the enterprise of "128 key project" of Taizhou City and one of top-10 environment-friendly enterprises of Taizhou City, and our credit is AAA grade. As an import and export business licensed enterprise, we developed CA and tartaric acid ester series of product independently. These products can meet leading international standards or fill the market blanks of China, and they are well sold in EU and Southeast Asia. Meanwhile, we are the biggest 7-ADCA manufacturer and supplier in China, with an annual output of 1,000 tons.The company not only has the authorization to import and export and also has three subordinate companies of Jiangsu Yuehua Pharmaceutical Co.,Ltd. Jiangsu Coastal Solid Waste Disposal Co., Ltd. and Zhejiang New Donghai Imp.& Exp. Co.,Ltd. All of them are healthily developing and striding forward.